top of page
Subscribe
Latest
All News
Podcast
Events
Directory
Contact
More
Use tab to navigate through the menu items.
Browse by category
All Posts
All News
Research
Spotlight
Industry & Products
Events & Training
Journal watch
Surgery News
Latest News
Top 10
obesity paradox
metabolic and bariatric surgery
Obesity treatment in the UK
Search
FDA approves Wegovy for MASH with moderate to advanced liver fibrosis
The FDA has approved Wegovy (semaglutide) injection 2.4 mg to treat adults with MASH with moderate to advanced liver scarring (fibrosis),...
Browse by tag
obesity
(341)
341 posts
bariatric surgery
(196)
196 posts
type 2 diabetes
(100)
100 posts
weight loss
(86)
86 posts
bariatric and metabolic surgery
(79)
79 posts
semaglutide
(74)
74 posts
glucagon-like peptide (GLP-1) analogues
(59)
59 posts
SOARD
(47)
47 posts
covid-19
(40)
40 posts
adolescent obesity
(39)
39 posts
Obesity Surgery
(38)
38 posts
Journal watch
(37)
37 posts
diabetes
(37)
37 posts
childhood obesity
(35)
35 posts
product launch
(30)
30 posts
tirzepatide
(29)
29 posts
laparoscopic sleeve gastrectomy
(28)
28 posts
weight gain
(27)
27 posts
Roux-en-Y gastric bypass (RYGB)
(26)
26 posts
product approval
(24)
24 posts
pregnancy
(24)
24 posts
New genetic risk score better predicts metabolic conditions
10 hours ago
Discontinuing semaglutide and tirzepatide, on average, does not lead to significant weight regain
1 day ago
Olympus launches next-generation VISERA ELITE III surgical imaging platform in US
5 days ago
Back to Top
bottom of page